Dyno Therapeutics Launches with US$2 B Deals with Novartis and Sarepta
By Michelle Liu
Pharma Deals Review: Vol 2020 Issue 5 (Table of Contents)
Published: 19 May-2020
DOI: 10.3833/pdr.v2020.i5.2538 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
On the same day as its emergence from stealth mode, Dyno Therapeutics has signed collaboration agreements with Novartis and Sarepta Therapeutics in deals potentially worth over US$2 B combined...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS